ARTICLE | Clinical News
Biosimilar trastuzumab: Phase III data
July 25, 2016 7:00 AM UTC
Top-line data from a double-blind, international Phase III trial in 725 patients with HER2-positive early breast cancer showed that ABP 980 plus paclitaxel and surgery was non-inferior to Herceptin t...